WO2010034649 2,3-substituted indazole or 4,5,6,7-tetrahydro-indazoles as FXR modulators against dyslipidemia and related diseases

Download
WO2010034649.pdf
Adobe Acrobat Document [5.6 MB]
Download

Scaffold: 4,5,6,7-tetrahydro-indazole

Biological target:

Farnesoid-X-receptor: FXR

Activity:

Modulator